Evidence map›Paper›PMID 34850024›Full record

ArticleThe Journal of clinical endocrinology and metabolism2022

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: the Pilot 4T Study.

Priya Prahalad, Victoria Y Ding, Dessi P Zaharieva, Ananta Addala, Ramesh Johari, David Scheinker, Manisha Desai, Korey Hood, David M Maahs

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Real-World Evidence of Automated Insulin Delivery System Use.Diabetes technology & therapeutics · 2024
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Determinants, implementation strategies, and mechanisms of the 4T Program.Journal of clinical & translational endocrinology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Priya PrahaladDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.ORCID 0000-0002-3894-4344
Victoria Y DingDepartment of Medicine, Division of Biomedical Informatics Research, Stanford University, Stanford, California 94304, USA.
Dessi P ZaharievaDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.
Ananta AddalaDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.ORCID 0000-0002-0508-4309
Ramesh JohariStanford Diabetes Research Center, Stanford University, Stanford, California 94304, USA.
David ScheinkerDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.ORCID 0000-0001-5885-8024
Manisha DesaiDepartment of Medicine, Division of Biomedical Informatics Research, Stanford University, Stanford, California 94304, USA.
Korey HoodDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.
David M MaahsDepartment of Pediatrics, Division of Pediatric Endocrinology, Stanford University, Stanford, California 94304, USA.ORCID 0000-0002-4602-7909
Stanford University · US

Funding

Stanford Center for Clinical & Translational Education and Research (Spectrum)UL1TR003142 · NCATS · STANFORD UNIVERSITY · PI O'HARA, RUTH M · 2019 to 2023
$45.0M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI HASSAN CHAIB · 2017 to 2026
$19.5M
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T StudyR18DK122422 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2020 to 2024
$3.2M
Training Research Leaders in Type 1 DiabetesK12DK122550 · NIDDK · STANFORD UNIVERSITY · PI MAAHS, DAVID MATTHEW · 2019 to 2023
$2.1M
NCATS NIH HHS UL1 TR003142NIDDK NIH HHS K12 DK122550NIDDK NIH HHS P30 DK116074NIDDK NIH HHS R18 DK122422NIH HHS P30DK116074NIH HHS R18DK122422
6 · The paper itself

Abstract

contextYouth with type 1 diabetes (T1D) do not meet glycated hemoglobin A1c (HbA1c) targets.

objectiveThis work aimed to assess HbA1c outcomes in children with new-onset T1D enrolled in the Teamwork, Targets, Technology and Tight Control (4T) Study.

methodsHbA1c levels were compared between the 4T and historical cohorts. HbA1c differences between cohorts were estimated using locally estimated scatter plot smoothing (LOESS). The change from nadir HbA1c (month 4) to 12 months post diagnosis was estimated by cohort using a piecewise mixed-effects regression model accounting for age at diagnosis, sex, ethnicity, and insurance type. We recruited 135 youth with newly diagnosed T1D at Stanford Children's Health. Starting July 2018, all youth within the first month of T1D diagnosis were offered continuous glucose monitoring (CGM) initiation and remote CGM data review was added in March 2019. The main outcomes measure was HbA1c.

resultsHbA1c at 6, 9, and 12 months post diagnosis was lower in the 4T cohort than in the historic cohort (-0.54% to -0.52%, and -0.58%, respectively). Within the 4T cohort, HbA1c at 6, 9, and 12 months post diagnosis was lower in those patients with remote monitoring than those without (-0.14%, -0.18% to -0.14%, respectively). Multivariable regression analysis showed that the 4T cohort experienced a significantly lower increase in HbA1c between months 4 and 12 (P < .001).

conclusionA technology-enabled, team-based approach to intensified new-onset education involving target setting, CGM initiation, and remote data review statistically significantly decreased HbA1c in youth with T1D 12 months post diagnosis.

Indexed as

Diabetes Mellitus, Type 1AdolescentBlood GlucoseBlood Glucose Self-MonitoringChildGlycated HemoglobinHumansTechnologyBlood GlucoseGlycated Hemoglobincontinuous glucose monitoringdiabetes technologyglycemic controlnew diagnosispediatricstype 1 diabetes

Identifiers

PMID34850024
PMCPMC8947228
OpenAlexW3215753986

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.